JP2023530046A5 - - Google Patents
Info
- Publication number
- JP2023530046A5 JP2023530046A5 JP2022560454A JP2022560454A JP2023530046A5 JP 2023530046 A5 JP2023530046 A5 JP 2023530046A5 JP 2022560454 A JP2022560454 A JP 2022560454A JP 2022560454 A JP2022560454 A JP 2022560454A JP 2023530046 A5 JP2023530046 A5 JP 2023530046A5
- Authority
- JP
- Japan
- Prior art keywords
- binds
- molecule
- antigen
- binding domain
- tl1a
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063004030P | 2020-04-02 | 2020-04-02 | |
| US63/004,030 | 2020-04-02 | ||
| PCT/US2021/025453 WO2021202926A1 (en) | 2020-04-02 | 2021-04-01 | Methods and combinations for dual targeting of tnf family members |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023530046A JP2023530046A (ja) | 2023-07-13 |
| JP2023530046A5 true JP2023530046A5 (https=) | 2024-04-10 |
Family
ID=77928094
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022560454A Pending JP2023530046A (ja) | 2020-04-02 | 2021-04-01 | Ｔｎｆファミリーのメンバーの二重標的化のための方法および組合せ |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20230159649A1 (https=) |
| EP (1) | EP4126960A4 (https=) |
| JP (1) | JP2023530046A (https=) |
| WO (1) | WO2021202926A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120917045A (zh) * | 2023-02-17 | 2025-11-07 | 普罗米修斯生物科学公司 | 治疗皮肤的抗tl1a抗体组合物和方法 |
| WO2024173865A2 (en) * | 2023-02-17 | 2024-08-22 | Prometheus Biosciences, Inc. | Anti-tl1a antibody compositions and methods of treatment in the kidney |
| CN121843714A (zh) | 2023-08-11 | 2026-04-10 | 派拉冈医疗公司 | Tl1a结合抗体及使用方法 |
| TW202545974A (zh) * | 2024-01-26 | 2025-12-01 | 美商旗艦先鋒創新有限責任（Ｖｉｉ）公司 | 免疫受體抑制蛋白及相關方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090317388A1 (en) * | 2005-05-25 | 2009-12-24 | Linda Burkly | Tl1a in treatment of disease |
| US20090136427A1 (en) * | 2007-09-18 | 2009-05-28 | La Jolla Institute For Allergy And Immunology | LIGHT Inhibitors For Asthma, Lung and Airway Inflammation, Respiratory, Interstitial, Pulmonary and Fibrotic Disease Treatment |
| KR20230109779A (ko) * | 2013-03-27 | 2023-07-20 | 세다르스-신나이 메디칼 센터 | Tl1a 기능 및 관련된 신호전달 경로의 저해에 의한섬유증 및 염증의 완화 및 반전 |
| WO2016127059A2 (en) * | 2015-02-05 | 2016-08-11 | La Jolla Institute For Allergy And Immunology | Light inhibitors for scleroderma and skin fibrotic disease treatment |
| US20180319889A1 (en) * | 2015-11-02 | 2018-11-08 | La Jolla Institute For Allergy & Immunology | Method and medicament for treating airway and/or lung diseases |
| CR20180365A (es) * | 2015-12-16 | 2018-09-28 | Amgen Inc | PROTEÍNAS DE UNIÓN AL ANTÍGENO BISPECÍFICO DE ANTI-TL1A/ANTI-TNF-a Y SUS USOS |
| CN121930331A (zh) * | 2019-09-13 | 2026-04-28 | 协和麒麟株式会社 | DcR3变体 |
-
2021
- 2021-04-01 US US17/916,548 patent/US20230159649A1/en active Pending
- 2021-04-01 EP EP21780761.9A patent/EP4126960A4/en active Pending
- 2021-04-01 WO PCT/US2021/025453 patent/WO2021202926A1/en not_active Ceased
- 2021-04-01 JP JP2022560454A patent/JP2023530046A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023530046A5 (https=) | ||
| CN101330930B (zh) | 心脏病治疗剂 | |
| RU2427589C2 (ru) | Антитела против интерлейкина-13 человека и их применение | |
| JP2020503362A5 (https=) | ||
| RU2434881C2 (ru) | Il-13 связывающие агенты | |
| JP2008511542A5 (https=) | ||
| JP2018533557A5 (https=) | ||
| JP2010521470A5 (https=) | ||
| JP2009541492A5 (https=) | ||
| JP2008502366A5 (https=) | ||
| JP2019505527A5 (https=) | ||
| JP2010517513A5 (https=) | ||
| TW201906866A (zh) | 酸性鞘磷脂酶缺乏症患者中異常骨狀況的治療 | |
| JP2011006464A (ja) | 喘息の治療における抗−ＴＮＦα抗体 | |
| JP7458790B2 (ja) | Ｉｌ－６阻害剤を含有する喘息の治療剤 | |
| TW202523696A (zh) | 抗-幹細胞因子抗體及其使用方法 | |
| JP2024521638A5 (https=) | ||
| WO2023020624A1 (en) | Use of alpha-enolase antagonist in treating fibrotic diseases | |
| CN114423455A (zh) | 用于治疗系统性硬化症的药物组合物 | |
| WO2023001305A1 (zh) | 缓解或治疗纤维化性疾病的药物组合物或药盒及其应用 | |
| WO2023048650A1 (en) | TREATMENT OF PRURITIS EMPLOYING ANTI-IL13Rα1 ANTIBODY OR BINDING FRAGMENT THEREOF | |
| JP2024511160A5 (https=) | ||
| JP2023526853A5 (https=) | ||
| US12473357B2 (en) | Use of antagonists of Th17 cytokines for the treatment of bronchial remodeling in patients suffering from allergic asthma | |
| US20250277042A1 (en) | TREATMENT OF PRURITIS EMPLOYING ANTI-IL13Ra1 ANTIBODY OR BINDING FRAGMENT THEREOF |